5 ESSENTIAL ELEMENTS FOR ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

In Segment A, participants will receive distinctive doses and schedules of oral ABBV-744 pill to establish Safe and sound dosing routine. Extra participants will be enrolled within the determined monotherapy dosign regimen. In Section B, contributors will get oral ruxolitinib and ABBV-744 will likely be offered as "add-on" therapy. In Section C, pa